HF Advisory Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.03M Buy
23,577
+1,165
+5% +$103K 0.61% 60
2026
Q2
$1.75M Buy
22,412
+3,795
+20% +$306K 0.54% 64
2026
Q1
$1.61M Buy
18,617
+2,010
+12% +$193K 0.55% 69
2025
Q4
$1.6M Buy
16,607
+1,372
+9% +$133K 0.56% 67
2025
Q3
$1.45M Buy
15,235
+1,102
+8% +$101K 0.53% 69
2025
Q2
$1.23M Buy
14,133
+1,106
+8% +$93.8K 0.49% 77
2025
Q1
$1.17M Buy
13,027
+4,873
+60% +$436K 0.51% 80
2024
Q4
$651K Buy
8,154
+281
+4% +$24.3K 0.3% 109
2024
Q3
$709K Buy
7,873
+992
+14% +$83.5K 0.33% 106
2024
Q2
$542K Buy
6,881
+2,262
+49% +$185K 0.28% 119
2024
Q1
$403K Buy
+4,619
New +$394K 0.23% 122

Other funds holding MDT

HF Advisory Group's MDT Position: Q3 2026 in Review

HF Advisory Group increased its Medtronic (MDT) stake by 5.2% in Q3 2026, buying an estimated $103K and bringing the position to 23,577 shares worth $2.03M. The position accounts for 0.61% of the portfolio, ranked #60.

HF Advisory Group first reported a position in MDT in Q1 2024 and has held it in 11 quarters since. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • HF Advisory Group held 23,577 shares of Medtronic worth $2.03M as of Q3 2026.
  • HF Advisory Group bought 1,165 Medtronic shares in Q3 2026, an estimated $103K.
  • Medtronic made up 0.61% of HF Advisory Group's portfolio in Q3 2026, its #60 holding.
  • HF Advisory Group first reported a position in Medtronic in Q1 2024 and has held it in 11 quarters since.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on HF Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.